...Pan Song; Mengxuan Shu; Luchen Yang; Xiaoyu Di; Peiwen Liu; Zhenghuan Liu; Jing Zhou; Qiang Dong Objective: The aim of this study was to evaluate the survival outcomes of radical prostatectomy (RP), external beam radiotherapy plus brachytherapy (EBRT + BT), and EBRT alone among elderly men (aged 70...

... therapy Radiotherapy Brachytherapy Metastatic prostate cancer Meta-analysis Data extraction was performed by X.-Y.W. and confirmed independently by X.-X.M. It mainly contains the following information: hazard ratios (HRs) with 95% confidence intervals (95% CIs) comparing men who underwent RT...

... plasmacytoma. The patient subsequently underwent percutaneous and endo-urethral high-dose-rate brachytherapy with a total dose of 42 Gy applied in 14 fractions. Besides an uncomplicated urinary tract infection and hyperpigmentation of the penis, the patient tolerated the radiotherapy well and is still free...

... is to clarify the clinical significance of neoadjuvant combined androgen blockade (CAB) for ≥6 months in patients with localized prostate cancer. Patients and Methods: A total of 431 patients with localized prostate cancer who underwent prostate brachytherapy (BT) with or without neoadjuvant CAB for ≥6 months...

... for the treatment of radiation-resistant prostate cancer were identified. Results: The primary treatment was external beam radiotherapy in 7 patients (53.8%) and brachytherapy in 6 patients (46.2%). The interval from radiotherapy to biochemical recurrence (BCR) varied from 12 to 108 months (median 48.9...

...) prostatic carcinomas. The phase II protocol comprises 46 Gy of external beam radiotherapy, followed by two insertions (1 week apart) of 137Cs MDR transurethral brachytherapy, each one delivering 8 Gy to a point 0.5 cm from the urethral walls. The treatment is completed with a 14-Gy boost to the prostatic...

...Holger Borchers; Michael Pinkawa; Andreas Donner; Timm P. Wolter; Norbert Pallua; Michael J. Eble; Gerhard Jakse Modern LDR brachytherapy has drastically reduced rectal toxicity and decreased the occurrence of rectourethral fistulas to <0.5% of patients. Therefore, symptoms of late-onset...

...Stephen Frederic Wyler; Daniel Stephan Engeler; Wolfhart Seelentag; Gerhard Ries; Hans-Peter Schmid Objective: To evaluate quality of life (QOL) after radical retropubic prostatectomy (RP) and low-dose-rate brachytherapy (BT). Methods: Between 2001 and 2004, RP or BT was performed in 212 patients...

...O.W. Hakenberg; M.P. Wirth; T. Hermann; P. Alken; G. Kovacs; R.P. Müller; L. Ahlemann; K. Schalkhäuser The increasing use of interstitial brachytherapy for the treatment of prostate cancer has made it necessary to discuss and establish guidelines for the application of this treatment modality...